Laura L. Kiessling | |
---|---|
Born | Lake Mills, Wisconsin |
Nationality | United States |
Fields | Chemical Biology |
Institutions | University of Wisconsin–Madison |
Alma mater |
Massachusetts Institute of Technology Yale University |
Known for | Research on multivalent protein-carbohydrate interactions; carbohydrate polymers |
Massachusetts Institute of Technology
Laura L. Kiessling is an American chemist, Steenbock Professor of Chemistry and Laurens Anderson Professor of Biochemistry, at the University of Wisconsin–Madison. Her interdisciplinary research interests focus on elucidating and exploiting the mechanisms of cell surface recognition processes, especially those involving protein-glycan interactions. Another major interest of her group is multivalency and its role in recognition and signal transduction. Her research combines tools from organic synthesis, polymer chemistry, structural biology, and molecular and cell biology.
After earning a B.S. in chemistry at the Massachusetts Institute of Technology (1983) and a Ph.D. in organic chemistry from Yale University (1989), Kiessling spent two years at the California Institute of Technology as an American Cancer Society postdoctoral Fellow before joining the faculty of the University of Wisconsin–Madison in 1991.
In addition to her current positions in the departments of chemistry and biochemistry at UW-Madison, she is the director of both the Keck Center for Chemical Genomics and the NIH Chemistry-Biology Interface Training Program as well as the editor-in-chief of ACS Chemical Biology.
In the first ten years of her career, Kiessling garnered a NSF National Young Investigator Award, Zeneca Excellence in Chemistry Award, a Dreyfus Teacher-Scholar Award, Alfred P. Sloan Fellowship, American Chemical Society (ACS) Arthur C. Cope Scholar Award, a MacArthur Foundation Fellowship, and was selected as one of the fifty top research and development “stars to watch” by Industry Week. Kiessling is also the cofounder of Quintessence Biosciences, a company that is working to translate her technological advances into cures for various diseases.